CClinicalTrials.gg
RecruitingNCT06106516ViVa-WARDUpdated Apr 6, 2025

Vital Sign Monitor Device Validation - WARD

An observational study in Surgery-Complications and Medical Complication, sponsored by Rigshospitalet, Denmark. Recruiting at 2 sites in Denmark. Per ClinicalTrials.gov, last updated 2025-04-06.

Sponsored by Rigshospitalet, Denmark · Observational

From the registry’s dates

  • Started Oct 2023; still recruiting 2 years 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Sex
All
01

Study summary

Aim: to assess the validity of CE/FDA approved vital sign monitor devices for clinical use in clinical setting.

Patients: up to 1000 medical and/or surgical patients will be included Intervention: Studies with various wirless or novel vital sign monitor devices control: Golden standard measurements or clinical standard devices Outcome: Agreement assessed by bias and limits of agreement between Intervention and control device.

Read the detailed description

Aim: to assess the validity of CE/FDA approved vital sign monitor devices for clinical use in clinical setting.

Patients: up to 1000 medical and/or surgical patients will be included. Intervention: Studies with various wireless or novel vital sign monitor devices control: Golden standard measurements or clinical standard devices Outcome: Agreement assessed by bias and limits of agreement between Intervention and control device. Other statistical assessments of agreement may be chosen as secondary outcomes, dependent on the data-structure

Setting: the study will be carried out in up to 76 hours with collection of vital sign data pre-, intra or postoperatively.

02

Conditions studied

  • Surgery-Complications
  • Medical Complication
03

In context

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Humans with or without medical or surgical complications in or out of hospital

Eligibility criteria

No inclusion or exclusion criteria

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Interventions

  • Devicenovel vital sign monitor

    Devices that are to be introduced into the clinic but where data from clinical relevant conditions such as complications are lacking to assess the validity under clinical conditions

06

What researchers measure

Primary outcomes

  1. Agreement between vital sign data from novel device and golden standard

    agreement between novel device and golden standard or clinical standard devices, assess by bias and limits of agreement

    Time frame: 76 hours

Secondary outcomes

  1. Description of data from novel device and golden standard

    descriptive statistics using parametric or non-parametric statistics where appropriate

    Time frame: 76 hours

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — data can be shared upon reasonable request

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06106516
Lead sponsor
Rigshospitalet, Denmark
Collaborators
Bispebjerg Hospital
Responsible party
Eske Kvanner Aasvang (Professor, Rigshospitalet, Denmark) — Principal investigator
First posted
Oct 30, 2023
Start date
Oct 24, 2023
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Apr 6, 2025

Study contacts

Eske K Aasvang, DMSci
Contact
eske.kvanner.aasvang.01@regionh.dk
+4526232076
Christian S Meyhoff, PhD
Contact
Christian.sylvest.meyhoff@regionh.dk
+4524910542

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion